⏳ Fetching live dividend data...
Home › Calculator › SELB Dividend Calculator 2026
Selecta Biosciences, Inc. · NASDAQ
Price: $0.88 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in SELB → $12655037939.60M in 10 years · $1,047,669,420,418,921.50/month
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to the research and development of innovative nanoparticle immunomodulatory medications aimed at treating and preventing various human ailments. The company's most advanced gene therapy initiative is SEL-302, currently in preclinical development to enhance therapeutic options for methylmalonic acidemia. Among its biologic therapies, SEL-212 is undergoing Phase III clinical trials for the management of chronic refractory gout. Selecta is also advancing potential treatments for a range of IgA-mediated conditions, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. Their gene therapy pipeline further includes SEL-313, a preclinical candidate targeting ornithine transcarbamylase deficiency, and SEL-399, which is designed to ascertain the optimal ImmTOR dosage for minimizing the formation of antibodies to AAV capsids. Additionally, they are developing gene therapies for conditions such as Pompe disease, Duchenne muscular dystrophy, limb-girdle muscular dystrophy, lysosomal storage disorders, and other autoimmune diseases. The company is also exploring tolerogenic therapies for primary biliary cholangitis and other autoimmune disorders. Selecta Biosciences, Inc. has established licensing and collaboration agreements with a diverse group of partners, including Takeda Pharmaceuticals USA, Inc., Swedish Orphan Biovitrum, Sarepta Therapeutics, Inc., Asklepios Biopharmaceutical, Inc., Massachusetts Institute of Technology, Shenyang Sunshine Pharmaceutical Co., Ltd., Ginkgo Bioworks Holdings, Inc., and IGAN Biosciences, Inc. Founded in 2007, Selecta Biosciences, Inc. is headquartered in Watertown, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SELB position with:
Real after-tax yield depends on where you live and how you hold SELB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 226.96% | 224.16% | $22,696 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 192.92% | 190.12% | $19,292 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 181.57% | 178.77% | $18,157 / yr |
| 🇬🇧 UK ISA | 0% | 226.96% | 224.16% | $22,696 / yr |
| 🇬🇧 UK Taxable | 8.75% | 207.10% | 204.30% | $20,710 / yr |
| 🇨🇦 TFSA | 0% | 226.96% | 224.16% | $22,696 / yr |
| 🇨🇦 CA Taxable | 25% | 170.22% | 167.42% | $17,022 / yr |
| 🇦🇺 Super (pension) | 15% | 192.92% | 190.12% | $19,292 / yr |
| 🇦🇺 AU Taxable | 30% | 158.87% | 156.07% | $15,887 / yr |
| 🇩🇪 DE Taxable | 26.375% | 167.10% | 164.30% | $16,710 / yr |
| 🇫🇷 FR Taxable | 30% | 158.87% | 156.07% | $15,887 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
SELB pays quarterly — 4 times per year. Next ex-div: TBD.
How SELB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SELB sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2024-01-02 | 178,000 | — | — | ||
| A-Award | 2024-01-02 | 228,000 | $0.66 | $149.4K | ||
| G-Gift | 2023-12-22 | 3,000 | — | — | ||
| A-Award | 2024-01-02 | 3,110,000 | $0.66 | $2.04M | ||
| A-Award | 2024-01-02 | 2,424,000 | — | — | ||
| A-Award | 2024-01-02 | 998,000 | $0.66 | $653.9K | ||
| A-Award | 2024-01-02 | 778,200 | — | — | ||
| A-Award | 2024-01-02 | 5,971,000 | $0.66 | $3.91M | ||
| A-Award | 2024-01-02 | 4,654,100 | — | — | ||
| A-Award | 2024-01-02 | 228,000 | $0.66 | $149.4K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SELB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Selecta Biosciences, Inc. (SELB) is currently trading at $0.88, 81% below its 52-week high. The current dividend yield is 226.96% based on an annual payout of $2.00 per share.
Selecta Biosciences, Inc. (SELB) is a healthcare stock currently trading at $0.88 with a dividend yield of 226.96%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever